Sun Pharma to consider internal restructuring of business

Drug major Sun Pharma said its board will meet later this week to consider internal restructuring of the business and to announce first quarter results.

The Mumbai-headquartered firm said in a filing to the BSE that its board on 10 August “would consider the internal restructuring of the business of the company with effect from 31 March, 2012”.

[caption id=“attachment_407012” align=“alignleft” width=“380”]  .Shares of Sun Pharma were trading at Rs 670.30 on the BSE in the afternoon trade. Reuters[/caption]

The board will also announce the financial results of the company for the first quarter ended 30 June, 2012. The board would also consider declaration of the interim dividend of Rs 4.25 per share of Re 1 each on equity shares of the company for the year ended March 31, 2012, the filing said.

More from Business fwire

China property sector distress deepens as second company runs into financial troubles Labour codes unlikely to be implemented this fiscal due to slow progress on drafting of rules, political considerations

Shares of Sun Pharma were trading at Rs 670.30 on the BSE in the afternoon trade, up 1.55 percent from its previous close.

PTI